Onlikon: Announcement on the actual controller of the company\'s stock pledged repurchase partial repurchase, release the pledge, and then carry out a stock pledge repurchase transaction
Onlikon: Announcement on the actual controller of the company\'s stock pledged repurchase partial repurchase, release the pledge, and then carry out a stock pledge repurchase transaction
Onlikon: Announcement on the extension and supplementary pledge of part of the company\'s actual controller\'s equity pledge
Onlykang: Announcement on shareholding information for the top ten shareholders and the top ten shareholders with unlimited sale conditions on share repurchases
Onlycan: Repurchase Report
Onlikon: Announcement on the plan to repurchase the company\'s shares and receipt of the “Loan Pledge”
Onlikon: Announcement on the expiration of the company\'s senior management holdings reduction plan
Onlikon: Announcement on the expiration of the repurchase period of the company\'s shares and the completion of the implementation of the repurchase
Zhejiang Anglikang Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Zhejiang Anglikang Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Zhejiang Anglikang Pharmaceutical: Orient Securities Co., Ltd.'s underwriting and sponsorship opinion for Zhejiang Anglikang Pharmaceutical Co., Ltd.'s use of idle funds from the 2020 non-public offering of stocks to temporarily supplement working capital.
Zhejiang Anglikang Pharmaceutical: Announcement regarding the temporary supplement of working capital using the idle raised funds from the non-public offering of stocks in 2020.
Zhejiang Anglikang Pharmaceutical: Announcement of Annual Equity Distribution Implementation in 2023
Zhejiang Anglikang Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Zhejiang Anglikang Pharmaceutical: Announcement on the progress of the repurchase of company shares
Zhejiang Anglikang Pharmaceutical: An indicative announcement on the upcoming expiration of the first employee stock ownership plan
Onlikang: Orient Securities Underwriting and Sponsorship Co., Ltd.'s inspection opinions on Zhejiang Anglikang Pharmaceutical Co., Ltd.'s adjustments to some of the implementation details of the 2020 non-public stock raising capital investment project
Onlyconn: Announcement on the progress of the repurchase of the company's shares
Onlyconn: Announcement on the progress of the repurchase of the company's shares
Onlikon: Announcement on the progress of the repurchase of the company\'s shares and the share repurchase ratio reaching 1%
No Data
No Data